Fluent

Fluent EBITDA Margin

Delisted

The EBITDA Margin of Fluent (TIUM.U.CN) as of Nov 7, 2026 is 32.15 %. In the previous year, EBITDA Margin was 21.96 % — a change of 46.40% (higher).

EBITDA Margin

32.15 %

YoY

46.40%

Last updated:

EBITDA Margin of Fluent is 2023 32.15 % . EBITDA Margin of Fluent was 2022 21.96 % . It decreases by 46.40% higher compared to the previous year.

The Fluent EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2019
-114.78 USD
Jan 1, 2020
-37.71 USD
Jan 1, 2021
-13.92 USD
Jan 1, 2022
21.96 USD
Jan 1, 2023
32.15 USD
The Fluent EBITDA Margin history
YEAREBITDA MarginYoY
32.15 %+46.40%
21.96 %-257.73%
-13.92 %-63.08%
-37.71 %-67.14%
-114.78 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fluent Stock analysis

What does Fluent do? Fluent Corp operates under the private label Fluent, selling medical cannabis products in Florida, Texas, and Pennsylvania. The company's products include oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, edibles, and accessories. Subsidiaries such as Cansortium Holdings LLC and Cansortium Florida, LLC handle production and sales, while Fluent Servicing, LLC manages servicing aspects. The company's revenue comes from direct sales of medical cannabis products through its licensed operations in multiple states. Fluent Corp's target customers are patients seeking medical cannabis treatments, with products tailored to various consumption methods. The company leverages its subsidiaries to maintain compliance and expand its market reach across different states. Sales are conducted through licensed dispensaries and medical cannabis programs, focusing on the healthcare segment of the cannabis industry. The business model relies on the production and sale of medical cannabis under the private label Fluent, utilizing subsidiaries to manage state-specific operations. Products are distributed through established medical cannabis channels, with no mention of additional revenue streams beyond product sales. The company's focus remains on the medical cannabis market, serving patients in Florida, Texas, and Pennsylvania. Fluent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluent stock

EBITDA Margin of Fluent is 32.15 % in 2023.

EBITDA Margin of Fluent changed from 21.96 % to 32.15 %, representing a 46.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Fluent since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Fluent with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Fluent

All Key Metrics — Fluent